The group of Korean medical researchers has developed a new anti-cancer immunity extracted from a plant, opening up new therapeutic opportunities for cancer patients.
It can also attack brain cancer cells.
The June 15 announcement by the Ministry of Science, Information and Communication and the Korea Future Plan said the team, led by Mr. Lee Chang-hwan of Ulsan University, developed a new substance. Derived from the plant called rehmannia (the Queen) , it is able to selectively destroy cancer cells.
In addition, this substance can attack brain cancer cells.
This study aims to develop anti-cancer immunity that can eliminate a way of selecting cancer cells with substances extracted from nature. This step is expected to apply to the treatment of many diseases such as cancer treatment and vaccine development.
The research results will be published in the latest issue of Korea's Oncoimmunology magazine.